CVS Health Corporation vs Johnson & Johnson — Stock Comparison
CVS Health Corporation (CVS) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Johnson & Johnson narrowly edges CVS Health Corporation on Q·Score (7.1 vs 6.4 out of 10), led by Quality (9.3 vs 3.9) and Valuation (7.3 vs 6.4). CVS Health Corporation scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst price targets imply similar upside for both: +9.6% for CVS and +9.6% for JNJ.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
86% of 28 covering analysts have a positive rating.
⚠ low return on equity (4%).
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
CVS vs JNJ: which stock scores better overall?
Based on Q·Score, Johnson & Johnson (JNJ) scores 7.1/10 versus CVS Health Corporation (CVS) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: CVS or JNJ?
CVS Health Corporation (CVS) scores higher on Growth (8.1/10 vs 5.1/10). CVS Health Corporation reports revenue growth (6.1% YoY) while Johnson & Johnson reports (9.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is CVS or JNJ more attractively valued?
Johnson & Johnson (JNJ) scores higher on Valuation (7.3/10 vs 6.4/10). CVS trades at 11.1× P/E versus JNJ at 18.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about CVS vs JNJ?
There are 26 analysts covering CVS with a consensus price target of $102.08, and 24 analysts covering JNJ with a consensus target of $252.96. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: CVS or JNJ?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 3.9/10). Net profit margin: CVS at 0.7%, JNJ at 21.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: CVS or JNJ?
Johnson & Johnson (JNJ) scores higher on Financial Health (6.5/10 vs 6.4/10). Market beta: CVS at 0.59, JNJ at 0.26. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of CVS and JNJ?
CVS Health Corporation (CVS) has a market capitalisation of $118.9B, while Johnson & Johnson (JNJ) has a market cap of $555.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do CVS or JNJ pay dividends?
CVS pays a dividend yield of 2.89%, while JNJ pays a dividend yield of 2.32%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →